RESEARCH TRIANGLE PARK – The longtime chief science and medical officer at ViiV Healthcare, which has a major presence, is stepping down in the near future.
John Pottage has been a fixture at ViiV since the company launched with a mission of combating HIV in 2009. The firm is majority owned by drug giant GlaxoSmithKline.
ViiV has developed a number of treatments that could help curb the AIDS menace.
Pottage will leave his roles by Oct. 1 and be replaced by Kimberly Smith and Harmony Garges, according to BiopharmaDive.
Smith is head of research. Garges leads medical affairs.